Cardiovascular Business: Cardiac amyloidosis increasingly common in US
New research shows the number of cardiac amyloidosis cases is rising in the U.S along with high rates of morbidity and mortality.
Amyloidosis is a disorder that happens when protein in the body misfolds and deposits into organs, which causes the organs to dysfunction. Although researches have long assumed the condition is on the rise, hospitalization trends for it remain unclear.
Brett Sperry, MD, Ibrahim Saeed, MD, and John Spertus, MD, all with Saint Luke's Mid America Heart Institute, and Shahzad Raza, MD, with Saint Luke's Cancer Institute, worked on the study published in the American Journal of Cardiology.
The team looked at nearly 157,000 patients hospitalized between 2005 and 2014. They noted that the overall number of hospital admissions in patients with amyloidosis more than doubled during the study period and offered a possible explanation for the trend.
"Given the increasing prevalence of hospitalizations in patients with amyloidosis, enhanced diagnostic and treatment options have the potential to improve care for a growing population of patients," the researchers said.
Read the full Cardiovascular Business article to learn more about the study.
